Announcement on Signing License Agreement by Holding Subsidiary
Filed with SSE · · 5 pages · Chinese
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. on 6ix
Earlier from Shanghai Fosun Pharmaceutical (Group)
- Notice of the Convening of the 2026 1st Extraordinary General Meeting, the 2026 1st A-share General Meeting and the 2026 1st H-share General Meeting
- Announcement on Completion of Issuance of the 2026 Phase I Science and Technology Innovation Bonds
- Announcement on Resolutions of the 23rd (Extraordinary) Meeting of the 10th Board of Directors
- Announcement on Pledge and Release of Pledge of Partial Shares of Shareholder
- Announcement on Resolutions of the 22nd (Extraordinary) Meeting of the 10th Board of Directors
Later from Shanghai Fosun Pharmaceutical (Group)
- Announcement on Progress in Signing the Licensing Agreement of Wholly-owned Subsidiary
- Self-Inspection Report on Trading of the Company's Shares by Insiders Related to the Spin-off and Listing of a Subsidiary on the Main Board of the Stock Exchange of Hong Kong Limited
- Announcement on Proposed Expansion of Financial Leasing Business by a Holding Subsidiary
- Announcement on Participating in Setting up Private Equity Investment Fund
- Announcement on Change of Chief Financial Officer
Follow Shanghai Fosun Pharmaceutical (Group) into a list and get an email when it puts out news.
Follow Shanghai Fosun Pharmaceutical (Group)